FDA rejects Correvio Pharma’s anti-arrhythmic drug Brinavess

Correvio Pharma said that the US Food and Drug Administration (FDA) decided not to approve its anti-arrhythmic drug Brinavess (vernakalant IV). In this connection, the ... Read More